Microscopic polyangiitis pathophysiology

Jump to navigation Jump to search

Microscopic polyangiitis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Microscopic polyangiitis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Radiation therapy

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Microscopic polyangiitis pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Microscopic polyangiitis pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Microscopic polyangiitis pathophysiology

CDC on Microscopic polyangiitis pathophysiology

Microscopic polyangiitis pathophysiology in the news

Blogs on Microscopic polyangiitis pathophysiology

Directions to Hospitals Treating Type chapter name here

Risk calculators and risk factors for Microscopic polyangiitis pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Ali Poyan Mehr, M.D. [2]Associate Editor(s)-in-Chief: Krzysztof Wierzbicki M.D. [3]

Overview

Pathogenesis

The etiology of Microscopic polyangiitis is not fully understood. However, certain hypothesizes have been made to determine possible factors that may trigger the disease. Triggers such as environmental factors and anti-neutrophil cytoplasmic antibodies.

Environmental factors

Environmental triggers such as exposure to silica have been found to influence the progression of the disease. However, its role in disease progression is not fully understood.[1]

Anti-neutrophil cytoplasmic antibodies (ANCA)

The majority of patients affected with Microscopic polyangiitis are positive for anti-neutrophil cytoplasmic antibodies with myeloperoxidase antigen activity. The presence of anti-neutrophil cytoplasmic antibodies activates neutrophil production, which produce reactive oxygen species and cause the release of lytic enzymes. These two outcomes induce detachment and lyses of the endothelium. The destruction of the endothelial cells results in necrotizing crescentic glomerulonephritis and necrotizing vasculitis of the pulmonary capillaries.

Genetics

Microscopic polyangiitis is correlated with HLA-DRB1*09:01-DQB1*03:03 haplotype in the Japanese population. This haplotype however, in the Caucasian population is not typically seen.[2]

Associated Conditions

Gross Pathology

Microscopic Pathology

References

  1. de Lind van Wijngaarden RA, van Rijn L, Hagen EC, Watts RA, Gregorini G, Tervaert JW; et al. (2008). "Hypotheses on the etiology of antineutrophil cytoplasmic autoantibody associated vasculitis: the cause is hidden, but the result is known". Clin J Am Soc Nephrol. 3 (1): 237–52. doi:10.2215/CJN.03550807. PMID 18077783.
  2. Tsuchiya N (2012). "Genetics of microscopic polyangiitis in the Japanese population". Ann Vasc Dis. 5 (3): 289–95. doi:10.3400/avd.ra.12.00062. PMC 3595849. PMID 23555527.

Template:WH Template:WS